{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:39:09Z","timestamp":1789011549000,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","plefa.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.plefa.2020.102110","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T19:51:08Z","timestamp":1588535468000},"page":"102110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["SC411 treatment can enhance survival in a mouse model of sickle cell disease"],"prefix":"10.1016","volume":"158","author":[{"given":"Celeste Y.C.","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Lopez-Toledano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Daak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett A.","family":"Clemons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane T.","family":"Citadin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick D.","family":"Sancilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian L.","family":"Rabinowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Minagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake T.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reggie H.C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung Wen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.plefa.2020.102110_bib0001","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ajh.21550","article-title":"Definitions of the phenotypic manifestations of sickle cell disease","volume":"85","author":"Ballas","year":"2010","journal-title":"Am. J. Hematol."},{"issue":"9","key":"10.1016\/j.plefa.2020.102110_bib0002","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/oxfordjournals.aje.a010288","article-title":"Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review","volume":"151","author":"Ashley-Koch","year":"2000","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.plefa.2020.102110_bib0003","first-page":"288","article-title":"Cerebrovascular accidents in sickle cell disease: rates and risk factors","volume":"91","author":"Ohene-Frempong","year":"1998","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.plefa.2020.102110_bib0004","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1182\/blood-2015-09-618579","article-title":"Central nervous system complications and management in sickle cell disease","volume":"127","author":"DeBaun","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.plefa.2020.102110_bib0005","first-page":"1","article-title":"Neurocognitive functioning in symptomatic adults with sickle cell disease: a description and comparison with unaffected siblings","author":"Martin","year":"2019","journal-title":"Neuropsychol. Rehabil."},{"key":"10.1016\/j.plefa.2020.102110_bib0006","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1182\/asheducation-2013.1.362","article-title":"Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies","volume":"2013","author":"Manwani","year":"2013","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"issue":"2-3","key":"10.1016\/j.plefa.2020.102110_bib0007","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3233\/CH-189012","article-title":"Inflammation in sickle cell disease","volume":"68","author":"Conran","year":"2018","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"10.1016\/j.plefa.2020.102110_bib0008","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev.nutr.25.051804.101917","article-title":"Polyunsaturated fatty acid regulation of genes of lipid metabolism","volume":"25","author":"Sampath","year":"2005","journal-title":"Annu. Rev. Nutr."},{"issue":"2","key":"10.1016\/j.plefa.2020.102110_bib0009","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1017\/S0029665111000061","article-title":"The differential effects of EPA and DHA on cardiovascular risk factors","volume":"70","author":"Cottin","year":"2011","journal-title":"Proc. Nutr. Soc."},{"issue":"3","key":"10.1016\/j.plefa.2020.102110_bib0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/070674370304800308","article-title":"Essential fatty acids and the brain","volume":"48","author":"Haag","year":"2003","journal-title":"Can. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.plefa.2020.102110_bib0011","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.plefa.2012.08.005","article-title":"A quantum theory for the irreplaceable role of docosahexaenoic acid in neural cell signalling throughout evolution","volume":"88","author":"Crawford","year":"2013","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"6","key":"10.1016\/j.plefa.2020.102110_bib0012","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1203\/PDR.0b013e318159a93a","article-title":"The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial","volume":"62","author":"Dunstan","year":"2007","journal-title":"Pediatr. Res."},{"issue":"2","key":"10.1016\/j.plefa.2020.102110_bib0013","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cardiores.2006.08.019","article-title":"Cardiovascular benefits of omega-3 fatty acids","volume":"73","author":"von Schacky","year":"2007","journal-title":"Cardiovasc. Res."},{"issue":"9","key":"10.1016\/j.plefa.2020.102110_bib0014","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/clc.23220","article-title":"Rounding the corner on residual risk: implications of REDUCE-IT for omega-3 polyunsaturated fatty acids treatment in secondary prevention of atherosclerotic cardiovascular disease","volume":"42","author":"Baum","year":"2019","journal-title":"Clin. Cardiol."},{"issue":"5","key":"10.1016\/j.plefa.2020.102110_bib0015","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3390\/nu10050620","article-title":"Comparison of the Incorporation of DHA in circulatory and neural tissue when provided as triacylglycerol (TAG), monoacylglycerol (MAG) or Phospholipids (PL) provides new insight into fatty acid bioavailability","volume":"10","author":"Destaillats","year":"2018","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.plefa.2020.102110_bib0016","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3390\/nu9091042","article-title":"Changes in bioavailability of omega-3 (DHA) through alpha-tocopheryl phosphate mixture (TPM) after oral administration in rats","volume":"9","author":"Libinaki","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.plefa.2020.102110_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1957360","article-title":"Advanced lipid technologies(R) (ALT(R)): a proven formulation platform to enhance the bioavailability of lipophilic compounds","volume":"2019","author":"Lopez-Toledano","year":"2019","journal-title":"J. Drug Deliv."},{"issue":"6","key":"10.1016\/j.plefa.2020.102110_bib0018","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1021\/jp3114946","article-title":"Lewis molecular acidity of ionic liquids from empirical energy-density models","volume":"117","author":"Contreras","year":"2013","journal-title":"J. Phys. Chem. B"},{"issue":"1","key":"10.1016\/j.plefa.2020.102110_bib0019","doi-asserted-by":"crossref","first-page":"H182","DOI":"10.1152\/ajpheart.00482.2016","article-title":"Interruption of perivascular sympathetic nerves of cerebral arteries offers neuroprotection against ischemia","volume":"312","author":"Lee","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.plefa.2020.102110_bib0020","article-title":"Measurement of the omega-3 index in dried blood spots","volume":"4","author":"Polreis","year":"2016","journal-title":"Ann. Clin. Lab. Res."},{"key":"10.1016\/j.plefa.2020.102110_bib0021","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.exer.2013.12.002","article-title":"Acridine orange leukocyte fluorography in mice","volume":"120","author":"Cahoon","year":"2014","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.plefa.2020.102110_bib0022","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12975-013-0276-z","article-title":"Fatty acid methyl esters and Solutol HS 15 confer neuroprotection after focal and global cerebral ischemia","volume":"5","author":"Lin","year":"2014","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.plefa.2020.102110_bib0023","article-title":"Utilizing the modified T-maze to assess functional memory outcomes after cardiac arrest","volume":"131","author":"Wu","year":"2018","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.plefa.2020.102110_bib0024","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.plefa.2018.11.011","article-title":"Palmitic acid methyl ester is a novel neuroprotective agent against cardiac arrest","volume":"147","author":"Lee","year":"2018","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"6","key":"10.1016\/j.plefa.2020.102110_bib0025","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.plefa.2005.03.005","article-title":"Steady-state haemoglobin level in sickle cell anaemia increases with an increase in erythrocyte membrane n-3 fatty acids","volume":"72","author":"Ren","year":"2005","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"3","key":"10.1016\/j.plefa.2020.102110_bib0026","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3390\/nu2030355","article-title":"Omega-3 fatty acids and inflammatory processes","volume":"2","author":"Calder","year":"2010","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.plefa.2020.102110_bib0027","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2018-000946","article-title":"Importance of maintaining a low omega-6\/omega-3 ratio for reducing inflammation","volume":"5","author":"DiNicolantonio","year":"2018","journal-title":"Open Heart"},{"issue":"9","key":"10.1016\/j.plefa.2020.102110_bib0028","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00277-005-1023-7","article-title":"Blood mononuclear cells and platelets have abnormal fatty acid composition in homozygous sickle cell disease","volume":"84","author":"Ren","year":"2005","journal-title":"Ann. Hematol."},{"issue":"8","key":"10.1016\/j.plefa.2020.102110_bib0029","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1182\/bloodadvances.2018030619","article-title":"Metabolomic and molecular insights into sickle cell disease and innovative therapies","volume":"3","author":"Adebiyi","year":"2019","journal-title":"Blood Adv."},{"issue":"15","key":"10.1016\/j.plefa.2020.102110_bib0030","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/bloodadvances.2018021444","article-title":"Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial)","volume":"2","author":"Daak","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.plefa.2020.102110_bib0031","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12878-017-0089-5","article-title":"Coagulation profile of Sudanese children with homozygous sickle cell disease and the effect of treatment with omega-3 fatty acid on the coagulation parameters","volume":"17","author":"Awoda","year":"2017","journal-title":"BMC Hematol."},{"issue":"22","key":"10.1016\/j.plefa.2020.102110_bib0032","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1182\/blood-2012-03-419879","article-title":"Impact of hydroxyurea on clinical events in the BABY HUG trial","volume":"120","author":"Thornburg","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.plefa.2020.102110_bib0033","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bcmd.2014.11.004","article-title":"Dietary supplementation with docosahexanoic acid (DHA) increases red blood cell membrane flexibility in mice with sickle cell disease","volume":"54","author":"Wandersee","year":"2015","journal-title":"Blood Cells Mol. Dis."},{"issue":"12","key":"10.1016\/j.plefa.2020.102110_bib0034","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1373\/clinchem.2006.072322","article-title":"Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids","volume":"52","author":"Cao","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.plefa.2020.102110_bib0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1476-511X-9-31","article-title":"RBC and WBC fatty acid composition following consumption of an omega 3 supplement: lessons for future clinical trials","volume":"9","author":"Witte","year":"2010","journal-title":"Lipids Health Dis."},{"issue":"2","key":"10.1016\/j.plefa.2020.102110_bib0036","first-page":"71","article-title":"Dynamic deformability of sickle red blood cells in microphysiological flow","volume":"4","author":"Alapan","year":"2016","journal-title":"Technol. (Singap. World Sci.)"},{"issue":"5","key":"10.1016\/j.plefa.2020.102110_bib0037","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/ajh.23958","article-title":"The delay time in sickle cell disease after 40 years: a paradigm assessed","volume":"90","author":"Ferrone","year":"2015","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.plefa.2020.102110_bib0038","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10739680802279394","article-title":"Sickle red cell-endothelium interactions","volume":"16","author":"Kaul","year":"2009","journal-title":"Microcirculation"},{"issue":"1","key":"10.1016\/j.plefa.2020.102110_bib0039","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bcmd.2015.03.014","article-title":"Omega 3 (n-3) fatty acids down-regulate nuclear factor-kappa B (NF-kappaB) gene and blood cell adhesion molecule expression in patients with homozygous sickle cell disease","volume":"55","author":"Daak","year":"2015","journal-title":"Blood Cells Mol. Dis."},{"issue":"24","key":"10.1016\/j.plefa.2020.102110_bib0040","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1182\/blood-2013-05-498311","article-title":"Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies","volume":"122","author":"Manwani","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.plefa.2020.102110_bib0041","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1753-4887.2010.00287.x","article-title":"Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids","volume":"68","author":"Wall","year":"2010","journal-title":"Nutr. Rev."},{"issue":"1","key":"10.1016\/j.plefa.2020.102110_bib0042","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1207\/S15326942DN2401_01","article-title":"Patterns of verbal long-term and working memory performance reveal deficits in strategic processing in children with frontal infarcts related to sickle cell disease","volume":"24","author":"Brandling-Bennett","year":"2003","journal-title":"Dev. Neuropsychol."},{"issue":"8","key":"10.1016\/j.plefa.2020.102110_bib0043","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.acn.2005.06.008","article-title":"Short-term memory in children with sickle cell disease: executive versus modality-specific processing deficits","volume":"20","author":"Schatz","year":"2005","journal-title":"Arch. Clin. Neuropsychol."},{"issue":"3","key":"10.1016\/j.plefa.2020.102110_bib0044","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/DBP.0b013e31824ba1b5","article-title":"Ameliorating attention problems in children with sickle cell disease: a pilot study of methylphenidate","volume":"33","author":"Daly","year":"2012","journal-title":"J. Dev. Behav. Pediatr."},{"issue":"5","key":"10.1016\/j.plefa.2020.102110_bib0045","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/MPH.0000000000000847","article-title":"Attention deficit hyperactivity disorder in children with sickle cell disease referred for an evaluation","volume":"39","author":"Acquazzino","year":"2017","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.plefa.2020.102110_bib0046","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/000992289403300902","article-title":"Neuropsychological impairment in children with sickle cell anemia and cerebrovascular accidents","volume":"33","author":"Cohen","year":"1994","journal-title":"Clin. Pediatr. (Phila)"},{"issue":"Pt 6","key":"10.1016\/j.plefa.2020.102110_bib0047","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/brain\/aws095","article-title":"Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher's disease","volume":"135","author":"Vitner","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.plefa.2020.102110_bib0048","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.nbd.2015.10.004","article-title":"Cognitive and behavior deficits in sickle cell mice are associated with profound neuropathologic changes in hippocampus and cerebellum","volume":"85","author":"Wang","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.plefa.2020.102110_bib0049","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/87565641.2016.1238474","article-title":"Working memory in children with neurocognitive effects from sickle cell disease: contributions of the central executive and processing speed","volume":"41","author":"Smith","year":"2016","journal-title":"Dev. Neuropsychol."},{"issue":"22","key":"10.1016\/j.plefa.2020.102110_bib0050","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1182\/blood-2014-09-551564","article-title":"How I treat and manage strokes in sickle cell disease","volume":"125","author":"Kassim","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.plefa.2020.102110_bib0051","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1586\/14737175.8.2.291","article-title":"Need for cognitive rehabilitation for children with sickle cell disease and strokes","volume":"8","author":"King","year":"2008","journal-title":"Expert Rev. Neurother."},{"issue":"1","key":"10.1016\/j.plefa.2020.102110_bib0052","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1212\/WNL.51.1.169","article-title":"Stroke in children and sickle-cell disease: baltimore-washington cooperative young stroke study","volume":"51","author":"Earley","year":"1998","journal-title":"Neurology"}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327820300685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327820300685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:07:50Z","timestamp":1760602070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327820300685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":52,"alternative-id":["S0952327820300685"],"URL":"https:\/\/doi.org\/10.1016\/j.plefa.2020.102110","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SC411 treatment can enhance survival in a mouse model of sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins, Leukotrienes and Essential Fatty Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plefa.2020.102110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Louisiana State University Health Science Center - Shreveport. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102110"}}